National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 14520-14521 [2014-05539]
Download as PDF
<![CDATA[
14520
Federal Register / Vol. 79, No. 50 / Friday, March 14, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Office of the Director, National
Institutes of Health; Notice of Meeting
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee to the Director,
National Institutes of Health (ACD).
The meeting is virtual and open to the
public. The HeLa Genome Data Access
working group will present a summary
of its assessment of requests to access
HeLa cell genome sequence data in the
NIH database of Genotype and
Phenotype (dbGaP). The HeLa Genome
Data Access working group report, as
well as instructions for joining the
virtual meeting, will be posted when
available on the ACD Web site (https://
acd.od.nih.gov). Additional information
about the HeLa Genome Data Access
working group can be accessed at
https://acd.od.nih.gov/hegda.htm.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Review of Career
Development (K) Applications.
Date: March 18, 2014.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Raul A. Saavedra, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS, NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–9223, saavedrr@
ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
sroberts on DSK5SPTVN1PROD with NOTICES
Dated: March 11, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05677 Filed 3–13–14; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: March 28, 2014.
Time: 10:00 a.m. to 2:00 p.m. Eastern Time.
Agenda: Presentation and discussion of the
HeLA Genome Data Access Working Group
Report.
Time 2:00 p.m. to 6:00 p.m. Eastern Time.
Agenda: Voting by ACD Members on
Requests for Access to HeLa Genome
Sequence Data.
Place: Virtual Meeting, Accessible at the
following Web site: https://helaacd.nih.gov/
access-requests/march-2014/.
Contact Information: Gretchen S. Wood,
Staff Assistant, Office of the Director, One
Center Drive, Building 1, Room 126,
Bethesda, Maryland 20892–0148, Telephone:
301–496–4272, woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person and must
be sent by 5:00 p.m. Eastern Time on March
25, 2014. Statements will be posted on the
ACD Web site and made accessible during
this virtual meeting.
Dated: March 10, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05538 Filed 3–13–14; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
19:18 Mar 13, 2014
Jkt 232001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel ‘‘NIAID Investigator Initiated
Program Project Applications (P01)’’.
Date: April 8, 2014.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 3251,
6700B Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Richard W. Morris, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 6700–B
Rockledge Drive, MSC–7616, Room 3251,
Bethesda, MD 20892–7616, 301–451–2663,
rmorris@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Integrated Preclinical/
Clinical Program for HIV Microbicides and
Biomedical Prevention (IPCP–MBP) (U19).
Date: April 9–10, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), Ballroom
A&B, 8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Betty Poon, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–6891, poonb@mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel ‘‘Innovative Assays to
Quantify the Latent HIV Reservoir (R21)’’.
Date: April 9, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3117, 6700B Rockledge Drive, Bethesda, MD
20817, (Telephone Conference Call).
E:\FR\FM\14MRN1.SGM
14MRN1
Federal Register / Vol. 79, No. 50 / Friday, March 14, 2014 / Notices
Contact Person: Raymond R. Schleef,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, (301) 451–3679,
schleefrr@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 10, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05539 Filed 3–13–14; 8:45 am]
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS).
Dated: March 11, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05675 Filed 3–13–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
sroberts on DSK5SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Chemical Spill Degradation
Byproducts.
Date: April 4, 2014.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree by Hilton, Raleigh
Durham Airport, 4810 Page Creek Lane,
Durham, NC 27703.
Contact Person: Sally Eckert-Tilotta, Ph.D.,
Scientific Review Administrator, Nat.
Institute of Environmental Health Sciences,
Office of Program Operations, Scientific
Review Branch, P.O. Box 12233, Research
Triangle Park, NC 27709 (919) 541–1446
eckertt1@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
VerDate Mar<15>2010
19:18 Mar 13, 2014
Jkt 232001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel NIDDK Ancillary
Studies.
Date: April 3, 2014.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Elena Sanovich, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–8886,
sanoviche@mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel RFA DK13–009 Type
1 Diabetes TrialNet Clinical Network Hub
(U01).
Date: April 8, 2014.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ann A Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 759, 6707 Democracy Boulevard,
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
14521
Bethesda, MD 20892–5452, 301–594–2242,
jerkinsa@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 10, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–05540 Filed 3–13–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Office
of AIDS Research Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Office of AIDS
Research Advisory Council.
Date: April 10, 2014.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: The next meeting of the Office of
AIDS Research Advisory Council (OARAC)
meeting will address NIH AIDS research
priorities. An update will be provided on the
latest changes made to the federal treatment
and prevention guidelines by the OARAC
Working Groups responsible for the
guidelines.
Place: National Institutes of Health, 5635
Fishers Lane Conference Center, Terrace
Level, Suite T–500, Rockville, MD 20852.
Contact Person: Joan Romaine, M.P.H.,
Supervisory Program Analyst, Office of AIDS
Research, Office of the Director, NIH, 5635
Fishers Lane, MSC 9310, Suite 4000,
Rockville, MD 20852, (301) 435–7693,
joan.romaine@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the OAR’s
home page: https://www.oar.nih.gov, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
E:\FR\FM\14MRN1.SGM
14MRN1
]]>Agencies
[Federal Register Volume 79, Number 50 (Friday, March 14, 2014)]
[Notices]
[Pages 14520-14521]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05539]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel ``NIAID Investigator Initiated
Program Project Applications (P01)''.
Date: April 8, 2014.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 3251, 6700B Rockledge
Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Richard W. Morris, Ph.D., Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700-B
Rockledge Drive, MSC-7616, Room 3251, Bethesda, MD 20892-7616, 301-
451-2663, rmorris@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel Integrated Preclinical/Clinical
Program for HIV Microbicides and Biomedical Prevention (IPCP-MBP)
(U19).
Date: April 9-10, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select),
Ballroom A&B, 8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Betty Poon, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616,
301-402-6891, poonb@mail.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel ``Innovative Assays to Quantify the
Latent HIV Reservoir (R21)''.
Date: April 9, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3117, 6700B Rockledge
Drive, Bethesda, MD 20817, (Telephone Conference Call).
[[Page 14521]]
Contact Person: Raymond R. Schleef, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 6700B Rockledge
Drive, MSC 7616, Bethesda, MD 20892-7616, (301) 451-3679,
schleefrr@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 10, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-05539 Filed 3-13-14; 8:45 am]
BILLING CODE 4140-01-P
